Characteristics	Total, n=30	Acute leukaemia	8 (27%)	First HCT	23 (77%)	Reduced intensity conditioning	16 (64%)	aGvHD grade 2 or more before HEV	7 (28%)
Age at HCT (years), median (range)	49 (9-69)	Lymphoma	9 (30%)	Autologous	5 (17%)	T-cell depletion	12 (40%)	cGvHD before HEV	7 (28%)
Male	15 (50%)	Complete remission at HCT	16 (53%)	Allogeneic	25 (83%)	Median time from HCT to HEV infection, months (range)	4.5 (-3, 182)	Immunosuppressive therapy at the diagnosis of HEV infection	19 (63%)

[Patients’ characteristics]